Timothy J Stuhlmiller Selected Research

Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)

1/2017

SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy J Stuhlmiller Research Topics

Disease

11	Neoplasms (Cancer) 05/2021 - 05/2013
2	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 10/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2014
2	Triple Negative Breast Neoplasms 01/2019 - 01/2017
2	Breast Neoplasms (Breast Cancer) 03/2018 - 04/2015
1	Brain Neoplasms (Brain Tumor) 04/2024
1	Disease Progression 04/2024
1	Glioma (Gliomas) 04/2024
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Tauopathies 01/2021
1	Neurilemmoma (Schwannoma) 01/2019
1	Meningioma (Meningiomas) 01/2018
1	Cardiotoxicity 10/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017

Drug/Important Bio-Agent (IBA)

8	Phosphotransferases (Kinase)IBA 01/2019 - 05/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 04/2024 - 05/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022 - 05/2014
2	Lapatinib (GW572016)FDA Link 05/2021 - 04/2015
2	trametinibIBA 01/2017 - 05/2014
1	Biomarkers (Surrogate Marker)IBA 04/2024
1	MicroRNAs (MicroRNA)IBA 04/2024
1	ulixertinibIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 05/2021
1	pertuzumabIBA 05/2021
1	Adenosine Triphosphate (ATP)IBA 05/2021
1	Monoclonal AntibodiesIBA 05/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	1- (1- (3- (methylsulfonyl)phenyl)- 7- propoxyindolizin- 3- yl)ethanoneIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	CaspasesIBA 01/2019
1	OTX015IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	Neurofibromin 2 (Merlin)IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 03/2018
1	ClaudinsIBA 03/2018
1	Sepharose (Agarose)IBA 03/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	EphA1 Receptor (Eph Receptor)IBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	Sunitinib (Sutent)FDA Link 10/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2017
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	Epithelial Sodium ChannelsIBA 01/2017
1	dabrafenibIBA 05/2014
1	Oncogene Proteins (Oncogene Protein)IBA 05/2014
1	VemurafenibIBA 05/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 10/2017